Two Sigma Investments’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,000
Closed -$1.6M 3775
2018
Q3
$1.6M Buy
12,000
+4,000
+50% +$599K ﹤0.01% 1633
2018
Q2
$1.27M Buy
8,000
+3,100
+63% +$460K ﹤0.01% 1964
2018
Q1
$701K Buy
4,900
+1,800
+58% +$246K ﹤0.01% 2243
2017
Q4
$412K Buy
+3,100
New +$396K ﹤0.01% 2563
2017
Q1
Sell
-22,600
Closed -$2.38M 3522
2016
Q4
$2.38M Buy
+22,600
New +$2.43M 0.01% 1357
2016
Q3
Sell
-2,000
Closed -$276K 3512
2016
Q2
$276K Buy
+2,000
New +$265K ﹤0.01% 2605
2015
Q3
Sell
-5,000
Closed -$573K 2989
2015
Q2
$573K Buy
5,000
+3,000
+150% +$359K ﹤0.01% 2030
2015
Q1
$239K Buy
+2,000
New +$267K ﹤0.01% 2404

Two Sigma Investments's ATHN Position: Q1 2019 in Review

Two Sigma Investments sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 30,883 shares — an estimated $4.07M sold.

Two Sigma Investments first reported a position in ATHN in Q1 2014 and held it in 8 quarters. The position peaked at $26.8M in Q4 2016. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

  • Two Sigma Investments reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
  • Two Sigma Investments sold 30,883 Athenahealth, Inc. shares in Q1 2019, an estimated $4.07M.
  • Two Sigma Investments first reported a position in Athenahealth, Inc. in Q1 2014 and held it in 8 quarters.
  • Two Sigma Investments's Athenahealth, Inc. position peaked at $26.8M in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.